After 7-Year Product Performance Report
Boston Scientific Defibrillators vs. the Competition
Boston Scientific CRT-Ds with EnduraLife Battery Technology demonstrated 87.2% survival probability at seven years 1-4 per PPR summary.
STAY UP TO DATE
Sign up to receive periodic emails about device longevity and how it impacts
patients, payers and the healthcare system.
patients, payers and the healthcare system.
